<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Monnig MA</submitter><funding>National Institute on Alcohol Abuse and Alcoholism</funding><funding>NIAAA NIH HHS</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>1644-1658</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12772440</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>49(8)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Alcohol consumption modulates immune function, in part by promoting microbial translocation. This process is thought to trigger an acute-phase immune response, contributing to alcohol-related immune modulation. However, most evidence on these effects arises from preclinical models. Additionally, existing human studies lack a placebo control, rely on a single alcohol dose, or fail to account for individual drinking history.&lt;h4>Methods&lt;/h4>This study examined in vivo concentrations of lipopolysaccharide (LPS, a marker of microbial translocation), acute-phase proteins, cytokines, and chemokines under low-dose alcohol, moderate-dose alcohol, and placebo using a within-subjects design in light and heavy drinkers. Participants (N = 32) were light drinkers (n = 15) and nontreat</pubmed_abstract><journal>Alcohol, clinical &amp; experimental research</journal><pubmed_title>Acute changes in immune biomarkers under low- and moderate-dose alcohol in light and heavy drinkers: A randomized, placebo-controlled trial.</pubmed_title><pmcid>PMC12772440</pmcid><funding_grant_id>K23 AA024704</funding_grant_id><funding_grant_id>P20 GM130414</funding_grant_id><funding_grant_id>P20GM130414</funding_grant_id><funding_grant_id>K23AA024704</funding_grant_id><pubmed_authors>Monnig MA</pubmed_authors><pubmed_authors>Lamb PS</pubmed_authors><pubmed_authors>Monti PM</pubmed_authors><pubmed_authors>Clark SE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Acute changes in immune biomarkers under low- and moderate-dose alcohol in light and heavy drinkers: A randomized, placebo-controlled trial.</name><description>&lt;h4>Background&lt;/h4>Alcohol consumption modulates immune function, in part by promoting microbial translocation. This process is thought to trigger an acute-phase immune response, contributing to alcohol-related immune modulation. However, most evidence on these effects arises from preclinical models. Additionally, existing human studies lack a placebo control, rely on a single alcohol dose, or fail to account for individual drinking history.&lt;h4>Methods&lt;/h4>This study examined in vivo concentrations of lipopolysaccharide (LPS, a marker of microbial translocation), acute-phase proteins, cytokines, and chemokines under low-dose alcohol, moderate-dose alcohol, and placebo using a within-subjects design in light and heavy drinkers. Participants (N = 32) were light drinkers (n = 15) and nontreat</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-06-06T10:52:15.459Z</modification><creation>2026-05-29T03:12:22.289Z</creation></dates><accession>S-EPMC12772440</accession><cross_references><pubmed>40588716</pubmed><doi>10.1111/acer.70106</doi></cross_references></HashMap>